A new study questions the controversial U.S. Preventive Service Task Force recommendations for
breast cancer screening, with data that shows starting at a younger
age and screening more frequently will result in more lives
saved.
Back in November 2009, the task force recommended women ages 50 to
74 should undergo mammogram screenings every two years.
This controversial recommendation differed from the American Cancer
Society’s guidelines which recommend yearly mammograms
for women starting at age 40.
Hendrick and Helvie used six model scenarios of screening mammography created by the Cancer Intervention and Surveillance Modeling Network. This is the same modeling data the task force considered.
The authors found if women begin yearly mammograms at age 40, it reduces breast cancer deaths by 40 percent.
When screening begins at 50 and occurs every other year, it reduces breast cancer deaths 23 percent.
71% improvement
The difference between these two screening strategies comes down
to 71 percent more lives saved with yearly screening beginning at
40.
Helvie said the task force guidelines created confusion among
women, leading some to forego mammography altogether.
“Mammography is one of the few screening tools that has been
proven to save lives and our analysis shows that for maximum
survival, annual screening beginning at 40 is best. This data gives
women more information to make an informed choice about the
screening schedule that’s best for them,” said
Helvie.
As part of their recommendation, the task force emphasized the
potential harms mammography can cause -- including pain during the
screening exam and anxiety from false-positives, which can lead to
additional imaging or biopsy.
Hendrick and Helvie found, on average, women ages 40 to 49 who are
screened annually will have a false-positive mammogram once every
10 years. They will get asked back for more tests once every 12
years and will undergo a false-positive biopsy once every 149
years.
Hendrick said the task force overemphasized the potential harms of
screening mammography, while ignoring the proven statistically
significant benefit of annual screening mammography starting at age
40.
“In addition, the panel ignored more recent data from
screening programs in Sweden and Canada showing that 40 percent of
breast cancer deaths are averted in women who get regular screening
mammography. Our modeling results agree completely with these
screening program results in terms of the large number of women
lives saved by regular screening mammography,” he said.
Helvie’s and Hendrick’s study appears in the February
issue of the American Journal of Roentgenology.